News Highlights: Top Company News of the Day - Friday at 9 AM ET

Docusign, After Riding Pandemic Wave, Aims to Expand Beyond E-Signature 
 

The company is hoping to boost revenue by selling a new platform that uses artificial intelligence to help store and analyze contracts.

 
CarMax Revenue Misses Estimates but Stock Rises on Earnings Beat 
 

Retail used unit sales fall 3.1% from the prior year.

 
Trump Media Stock Tumbles 28% in 5 Days 
 

The shares are down 41.6% on the month following Trump's historic conviction in his hush money trial.

 
Robert Winnett Won't Become Editor of the Washington Post 
 

Telegraph Deputy Editor Robert Winnett will no longer join the Washington Post as its top editor, a reversal that comes as he had been under scrutiny for tactics he used as a journalist in the U.K.

 
Perpetual Sells Bonds, Cuts Cash as Fed Slows Quantitative Tightening 
 

Australian money manager Perpetual sold off some government bonds and cut its cash holdings in its flagship fixed-income fund following the Federal Reserve's recent decision to reduce its balance sheet at a slower pace.

 
Carlsberg's Improved Offer for Britvic Rejected 
 

Carlsberg said it was considering its position after Britvic rejected an improved offer valuing the U.K. soft-drinks maker at more than $3.9 billion.

 
Why Your Starbucks Frappuccino Is Now Half-Price 
 

The coffee chain, long known for premium brews, is pumping out more deals to woo price-sensitive customers.

 
Copper Producer Aurubis Appoints New CEO After Metal Theft 
 

Aurubis, one of the world's largest copper producers, named a new chief executive in a sweeping restructuring of its executive board following cases of metal theft at a plant in Germany.

 
Car Dealers Are in Turmoil as Cyber Incidents Strike Software Provider 
 

CDK Global has shut down its systems serving nearly 15,000 auto dealers, and some of the businesses are resorting to pen and paper to carry out their sales operations.

 
Eli Lilly Files More Lawsuits at Sellers of Counterfeit Mounjaro, Zepbound 
 

The pharmaceutical company said it filed legal actions against med-spas, wellness centers and other entities that sell products purportedly containing tirzepatide, the antidiabetic medication Eli Lilly sells under the brand names Mounjaro and Zepbound.

(END) Dow Jones Newswires

June 21, 2024 09:15 ET (13:15 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.